Clinical utility of the maximum area of detrusor tracing measurement in the urodynamic studies in pediatric population diagnosed with neuropathic bladder: A pilot study.

Autors de IIS La Fe
Abstract
INTRODUCTION: Neuropathic bladder (NB) is a lower urinary tract dysfunction (LUTD) that may lead to kidney failure. Urodynamic study is the gold standard for its diagnosis and follow-up. A classic prognostic parameter to predict the risk of upper urinary tract damage (UUTD) is the detrusor leak point pressure (DLPP)?=??40?cmH2O, although this factor alone may lack prognostic value. The area under the curve (AUC) of the detrusor pressure tracing has been recently described as a prognostic factor. AIM: To analyze the clinical utility of the AUC of the detrusor pressure tracing in the pediatric population (<15 years). METHODS: Retrospective study of urodynamic recordings in pediatric population with NB from 2011 to 2020. The following variables were evaluated: detrusor leak point pressure?=?40?cmH2O, voiding dysfunction, bladder compliance and overactivity. The sample is classified according to clinical-radiological findings at the time of the UD. AUC is calculated using Newton-Cotes rules (trapezium, Simpson's rule) and its indexes are calculated according to bladder capacity (TI: Trapezium Index, SI: Simpson Index). Statistical significance: P?<?.05. RESULTS: Fifty-five recordings are analyzed. Unfavorable clinical condition was identified in 41.8% (n?=?23) patients. Voiding dysfunction, low compliance and both indexes were associated with an unfavorable clinical condition (P?<?.05). ROC analysis showed the following AUC for the new indexes: TI (0.736, P?=?0.0006), SI (0.755, P?=?.0001) with a cut-off value of 10,69 and 8 cmH2O·s/cc, respectively. We did not find differences in the diagnostic performance between them (P?>?.05). CONCLUSIONS: The analyzed indexes are useful in the diagnosis of patients with NB and unfavorable clinical condition.
Dades de la publicació
- ISSN/ISSNe:
- 2173-5786, 2173-5786
- Tipus:
- Article
- Pàgines:
- 122-129
- PubMed:
- 35125339
Actas Urologicas Espanolas
Documents
- No hi ha documents
Filiacions
Keywords
- Diagnosis; Diagnóstico; Neuropathic bladder; Paciente pediátrico; Pediatric patient; Vejiga neuropática
Projectes associats
ESTUDIO ALEATORIZADO Y ABIERTO DE 24 SEMANAS PARA EVALUAR LA SEGURIDAD Y LA EFICACIA DE FESOTERODINA EN SUJETOS DE 6 A 17 AÑOS CON SÍNTOMAS DE HIPERACTIVIDAD DEL DETRUSOR ASOCIADA CON UN TRASTORNO NEUROLÓGICO (HIPERACTIVIDAD NEURÓGENA DEL DETRUSOR).
Investigador Principal: JOSÉ ANTONIO MARCH VILLALBA
A0221047 . 2017
ESTUDIO DE FASE III RANDOMIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO, DE ITACITINIB O PLACEBO EN COMBINACIÓN CON CORTICOSTEROIDES PARA EL TRATAMIENTO DE PRIMERA LÍNEA DE LA ENFERMEDAD DE INJERTO CONTRA HUÉSPED EN FASE AGUDA.
Investigador Principal: JAIME SANZ CABALLER
INCB39110-301 . 2018
PROTOCOLO UMBRELLA SIOP-RTSG 2016 – INVESTIGACIÓN INTEGRADA Y GUÍAS PARA DIAGNÓSTICO Y TERAPIA ESTANDARIZADOS DE TUMORES DE RIÑÓN EN NIÑOS, ADOLESCENTES Y ADULTOS JÓVENES.
Investigador Principal: JULIA BALAGUER GUILL
DRKS00011208 . 2019
ESTUDIO CLÍNICO DE FASE II/III, ALEATORIZADO Y PROSPECTIVO, COMPARATIVO DE BEGEDINA® FRENTE AL TRATAMIENTO CONVENCIONAL EN LA ENFERMEDAD INJERTO CONTRA HUÉSPED AGUDA RESISTENTE A LOS ESTEROIDES.
Investigador Principal: GUILLERMO SANZ SANTILLANA
ADN011
ESTUDIO EN FASE III, ALEATORIZADO, CONTROLADO, INTERNACIONAL, CON RIGOSERTIB EN COMPARACIÓN CON UN TRATAMIENTO A ELECCIÓN DEL MÉDICO, EN PACIENTES CON SÍNDROME MIELODISPLÁSICO TRAS EL FRACASO DE UN HIPOMETILANTE.
Investigador Principal: GUILLERMO SANZ SANTILLANA
04-30 . 2016
MANEJO INICIAL DE LA DILATACIÓN PIELOCALICIAL DE DIAGNÓSTICO PRENATAL.
Investigador Principal: MARIA PEREZ CHAMORRO
UNE-AMO-2019-01 . 2020
Estudio abierto, de primera administración en humanos, agente único, con aumento escalonado de la dosis para evaluar la seguridad, farmacocinética, farmacodinamia y actividad antitumoral de SAR442257 en pacientes con mieloma múltiple y linfoma no Hodgkin recidivantes y refractarios
Investigador Principal: JAVIER DE LA RUBIA COMOS
TED16364 . 2021